This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Bayer Healthcare LLC, Bayer Intellectual Property Gmbh, Bayer Pharmaceuticals Corporation. Active years: 2009-2013.
Company Filing History:
1 out of 789 
1 out of 721 
1 out of 71 
Years Active: 2009-2013
Title: Andrea McClure: Innovator in Cancer Treatment
Introduction
Andrea McClure is a prominent inventor based in West Haven, CT (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments for cancer and other hyperproliferative diseases. With a total of 3 patents to her name, McClure's work is paving the way for new therapeutic options.
Latest Patents
Among her latest patents is the invention titled "Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases." This invention relates to novel compounds of formula (I), which are designed to be used in pharmaceutical compositions for the treatment of cancer. Another significant patent is for "Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis." This invention focuses on pyrrolotriazine compounds and their use in preventing and treating hyper-proliferative disorders.
Career Highlights
Andrea McClure has worked with notable companies in the pharmaceutical industry, including Bayer Pharmaceuticals Corporation and Bayer Intellectual Property GmbH. Her experience in these organizations has contributed to her expertise in drug development and innovation.
Collaborations
Throughout her career, McClure has collaborated with esteemed colleagues, including Julie A. Dixon and Barton W. Phillips. These partnerships have enhanced her research and development efforts in the pharmaceutical field.
Conclusion
Andrea McClure is a trailblazer in the realm of cancer treatment innovations. Her patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.